Unit dosage composition of AKT inhibitor
AssigneeNanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
InventorsLei Miao, Ying Tang, He Tian, Changyou Ma, Jian Wu, Dan Xu, Chunxia Zhu, Zhoushan Tian
Life of this patent
Estimating the term…
Abstract
A unit dosage composition of an AKT inhibitor, and in particular, relates to a pharmaceutical composition in unit dosage form includes a compound of formula I-0 or a pharmaceutically acceptable salt thereof, wherein the mass of the compound I-0 or the pharmaceutically acceptable salt thereof is 5 mg to 400 mg calculated as free base.
Claims21
A unit dosage pharmaceutical composition comprising compound I-0 or a pharmaceutically acceptable salt thereof, wherein the mass of the compound I-0 or the pharmaceutically acceptable salt thereof is 5 mg to 400 mg calculated as a free base, and the compound I-0 has the following structure:
- wherein, R is selected from the group consisting of C1-C4 alkyl and C3-C6 cycloalkyl;
- and
- X is selected from the group consisting of CH2 and O.
Dependencies are inferred from the claim text.